vgll3 Gene Links Growth, Aging, Cancer
Analysis based on 6 articles · First reported Jun 02, 2026 · Last updated Jun 03, 2026
This discovery could significantly impact the biotechnology and pharmaceutical industries by opening new avenues for drug development targeting aging and cancer. Companies involved in genetic research and therapies may see increased investment and research opportunities, potentially leading to new treatments and extended healthy lifespans.
An international team of researchers, led by Dr. Eitan Moses, Dr. Marva Bergman, and Prof. Itamar Harel at Hebrew University of Jerusalem, in collaboration with Technion – Israel Institute of Technology and the University of East Anglia, has identified the vgll3 gene as a key factor linking early-life growth and reproduction with accelerated aging and increased cancer risk. Using CRISPR technology on Nothobranchius furzeri, they found that modifying vgll3 led to faster growth and earlier sexual maturity but also reduced lifespans and a higher incidence of age-related tumors. This provides experimental evidence for the theory of antagonistic pleiotropy, where genes offer early-life advantages at the cost of long-term health. The findings, published in Tata Communications, have implications for understanding human development, aging, and age-related diseases, potentially leading to new strategies for cancer prevention and healthy lifespan extension.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard